<p style="text-align: justify;">Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of<br />Transfusional Iron Overload in Patients with Sickle Cell Disease<br />or Other Anemias</p>

drug protocol number

LA38-EXT

drug sponsor

ApoPharma

drug study

Deferiprone

drug trial site

Aseer Central Hospital

drug status

Ongoing

drug phase